The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice

CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice

(2016) Marta Kruk-Slomka et al.   BEHAVIOURAL BRAIN RESEARCH

The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801

(2016) Marta Kruk-Slomka et al.   NEUROTOXICITY RESEARCH

Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands

(2016) Marta Kruk-Slomka et al.   NEURAL PLASTICITY

Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system

(2015) Marta Kruk-Slomka et al.   BEHAVIOURAL BRAIN RESEARCH

Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission

(2015) Jimok Kim et al.   JOURNAL OF PHYSIOLOGY-LONDON

Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats

(2015) Somayeh Barzegar et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

(2014) Shin Fukuda et al.   BMC MUSCULOSKELETAL DISORDERS

Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats

(2014) Hai-Ying Zhang et al.   NEUROPSYCHOPHARMACOLOGY

Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

(2014) Hai-Ying Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice

(2014) Ramy Khella et al.   PSYCHOPHARMACOLOGY

Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain

(2014) Valéria Almeida et al.   SCHIZOPHRENIA RESEARCH

Gone to Pot – A Review of the Association between Cannabis and Psychosis

(2014) Rajiv Radhakrishnan et al.   Frontiers in Psychiatry

Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies

(2012) Patrik Roser et al.   CURRENT PHARMACEUTICAL DESIGN

Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies

(2012) Charlotte Rapp et al.   CURRENT PHARMACEUTICAL DESIGN

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia

(2012) Raquel Levin et al.   CURRENT PHARMACEUTICAL DESIGN

Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia

(2012) Fu-Chun Zhou et al.   SCHIZOPHRENIA RESEARCH

Cannabis Use and Earlier Onset of Psychosis

(2011) Matthew Large et al.   ARCHIVES OF GENERAL PSYCHIATRY

AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

(2011) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

(2011) Zheng-Xiong Xi et al.   NATURE NEUROSCIENCE

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

(2011) Antonio Ortega-Alvaro et al.   NEUROPSYCHOPHARMACOLOGY

Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists

(2010) R. Pertwee   CURRENT MEDICINAL CHEMISTRY

Animal models of neuropsychiatric disorders

(2010) Eric J Nestler et al.   NATURE NEUROSCIENCE

Clinical Physiology and Mechanism of Dizocilpine (MK-801): Electron Transfer, Radicals, Redox Metabolites and Bioactivity

(2010) Peter Kovacic et al.   Oxidative Medicine and Cellular Longevity

Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats

(2010) Vera Bubenikova-Valesova et al.   PSYCHOPHARMACOLOGY

Brain Cannabinoid CB2 Receptor in Schizophrenia

(2009) Hiroki Ishiguro et al.   BIOLOGICAL PSYCHIATRY

Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

(2009) Q.-R. Liu et al.   GENES BRAIN AND BEHAVIOR

Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1−/− and not CB2−/− mice in models of acute and persistent pain

(2009) Nova M.H. Sain et al.   NEUROPHARMACOLOGY

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

(2008) Daniela Vigano et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

(2008) I. Racz et al.   JOURNAL OF NEUROSCIENCE

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review

(2008) I SVIZENSKA et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

(2008) Emmanuel S. Onaivi et al.   PLoS One

Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation

(2007) K L Wright et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid CB2receptors in human brain inflammation

(2007) C Benito et al.   BRITISH JOURNAL OF PHARMACOLOGY